Immunofluorescence Study of Endogenous YAP in Mammalian Cells
- 1.8k Downloads
Immunocytochemistry enables determination of cellular localization and relative abundance of proteins. This protocol describes a rapid and cost-effective approach to study the cellular localization of YAP (and TAZ), the transcriptional co activators of the Hippo pathway, in mammalian cells. Cells are seeded onto coated cover slips, cultivated and treated as required. Subsequently, they are chemically fixed, and cellular proteins are fluorescently labeled by means of specific antibodies. Multiplexing antibodies enables ascertaining the subcellular localization of YAP and TAZ and thereby also the activation state of the Hippo pathway in various cell types.
Key wordsImmunofluorescence Immunocytochemistry Cellular localization YAP Hippo pathway
Members of the Gram Hansen lab are thanked for their comments as well as for helping taking the photos for Figs. 1, 2, 3, 4, 5, and 6. Work ongoing in the Gram Hansen lab is supported by a Chancellor’s Fellowship start-up fund and by the Wellcome Trust-University of Edinburgh Institutional Strategic Support Fund. We acknowledge the technical support and guidance provided by the Centre for Reproductive Health SuRF Histology and imaging as well as the Centre for Inflammation Research imaging staff.
- 6.Yu FX, Zhao B, Panupinthu N, Jewell JL, Lian I, Wang LH, Zhao J, Yuan H, Tumaneng K, Li H, Fu XD, Mills GB, Guan KL (2012) Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 150(4):780–791. https://doi.org/10.1016/j.cell.2012.06.037 CrossRefPubMedPubMedCentralGoogle Scholar
- 12.Koontz LM, Liu-Chittenden Y, Yin F, Zheng Y, Yu J, Huang B, Chen Q, Wu S, Pan D (2013) The Hippo effector Yorkie controls normal tissue growth by antagonizing scalloped-mediated default repression. Dev Cell 25(4):388–401. https://doi.org/10.1016/j.devcel.2013.04.021 CrossRefPubMedPubMedCentralGoogle Scholar
- 13.Jiao S, Wang H, Shi Z, Dong A, Zhang W, Song X, He F, Wang Y, Zhang Z, Wang W, Wang X, Guo T, Li P, Zhao Y, Ji H, Zhang L, Zhou Z (2014) A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer. Cancer Cell 25(2):166–180. https://doi.org/10.1016/j.ccr.2014.01.010 CrossRefPubMedGoogle Scholar
- 14.Zhang W, Gao Y, Li P, Shi Z, Guo T, Li F, Han X, Feng Y, Zheng C, Wang Z, Li F, Chen H, Zhou Z, Zhang L, Ji H (2014) VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex. Cell Res 24(3):331–343. https://doi.org/10.1038/cr.2014.10 CrossRefPubMedPubMedCentralGoogle Scholar